TRPV4−/− mice receiving isoproterenol treatment had preserved cardiac dimensions and function and exhibited significantly less collagen deposition and arrhythmia inducibility compared to TRPV4+/+. This evidence concerns the gene TRPV4 and cardiac arrhythmia.